Discovery of high-affinity peptide ligands for vancomycin

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Vancomycin is a critical antibiotic for Gram-positive bacteria, including MRSA.
• Its antibacterial action relies on binding the Lys-D-Ala-D-Ala (Kaa) motif of bacterial cell wall precursors.
• A free carboxyl group on the terminal D-Ala of Kaa is essential for vancomycin binding.

Purpose of the Study:

• To develop a novel synthetic strategy for one-bead-one-compound (OBOC) peptide libraries with free carboxyl ends.
• To discover novel Kaa-based peptide ligands that bind vancomycin with higher affinity.
• To optimize lead compounds through focused peptidomimetic libraries.

Main Methods:

• Development of "OBOC inverted" combinatorial peptide libraries with free D-Ala-D-Ala carboxyl termini.
• Screening of these libraries against vancomycin to identify binding ligands.
• Design, synthesis, and screening of focused peptidomimetic libraries for enhanced affinity.

Main Results:

• Identification of novel peptide ligands that bind vancomycin.
• Discovery of peptidomimetic ligands exhibiting higher binding affinity than Kaa.
• A lead peptidomimetic ligand demonstrated a 50-fold increase in binding affinity (K(D) = 1.03 µM) compared to Kaa (K(D) = 50 µM).

Conclusions:

• The "OBOC inverted" library approach is effective for discovering high-affinity vancomycin ligands.
• Optimized peptidomimetics show potential for improved vancomycin-based therapeutics.
• This strategy advances the development of novel antibiotics targeting resistant bacteria.